Filter
4870
Filtered Results: 4870
Text search:
medicines
availability
Featured
Recommendations
458
New Publications
1347
Language
Document type
No document type
2744
Studies & Reports
913
Guidelines
620
Manuals
235
Strategic & Response Plan
190
Training Material
57
Fact sheets
57
Situation Updates
34
Resource Platforms
8
Infographics
7
Brochures
3
Online Courses
2
Countries / Regions
India
235
Global
185
Kenya
166
Ethiopia
120
South Africa
115
Uganda
111
Nepal
106
Nigeria
100
Sierra Leone
97
Malawi
97
Liberia
93
Tanzania
87
Africa
87
Western and Central Europe
85
Zambia
71
Bangladesh
71
Myanmar / Burma
68
Latin America and the Carribbean
66
Ghana
62
Rwanda
62
Ukraine
53
Syria
49
Namibia
49
Philippines
42
Congo, Democratic Republic of
41
South–East Asia Region
39
Zimbabwe
38
Senegal
31
Lesotho
30
East and Southern Africa
29
Asia
29
Guinea
28
Eastern Europe
28
Mozambique
27
Haiti
26
West and Central Africa
26
Venezuela
23
Cambodia
22
Burkina Faso
21
Botswana
21
Middle East and North Africa
21
South Sudan
20
Cameroon
16
Indonesia
16
Eastern Europe and Central Asia
16
Eswatini/ Swaziland
14
Brazil
14
Yemen
14
Russia
14
Sudan
13
Pakistan
12
Afghanistan
12
Germany
12
Lebanon
11
Benin
11
Thailand
10
Western Pacific Region
10
Moldova
10
USA
9
Jordan
9
Colombia
9
Somalia
8
North Macedonia
8
Mali
7
Côte d’Ivoire / Ivory Coast
7
Georgia
7
Peru
6
Laos
6
Vietnam
6
North America
6
Niger
5
Iraq
5
Central African Republic
5
Ecuador
5
Sri Lanka
5
Poland
5
Albania
5
Southern Africa
5
Tajikistan
5
Kyrgyzstan
5
Kazakhstan
5
Hungary
4
Burundi
4
Libya
4
Madagascar
4
Chile
4
Paraguay
4
Morocco
3
Turkey
3
Chad
3
China
3
Angola
3
Romania
3
Jamaica
3
Mauritius
3
Belarus
3
Togo
2
Egypt
2
Mauritania
2
Papua New Guinea
2
Argentina
2
Serbia
2
Bolivia
2
Mexico
2
Other region
2
Bhutan
2
Palestine
2
Canada
2
Qatar
2
Bulgaria
2
Iran
2
Gabon
2
Turkmenistan
2
Tunisia
2
United Kingdom
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Saudi Arabia
1
Gambia
1
Malaysia
1
Austria
1
Switzerland
1
El Salvador
1
Guatemala
1
Fiji
1
Solomon Islands
1
Italy
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Estonia
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
France
1
Maldives
1
Norway
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1960
Clinical Guidelines
409
Public Health
303
Women & Child Health
228
Key Resources
170
Capacity Building
81
Pharmacy & Technologies
62
Annual Report MEDBOX
2
Toolboxes
HIV
415
Mental Health
353
COVID-19
350
TB
259
AMR
214
Pharmacy
136
NCDs
135
Planetary Health
128
Caregiver
127
Disability
126
Rapid Response
123
NTDs
123
Conflict
117
Ebola
112
Global Health Education
67
Refugee
58
Natural Hazards
50
Health Financing Toolbox
38
Zika
22
Specific Hazards
20
Cholera
16
Polio
11
Social Ethics
11
Typhoon
1
Health Financing
1
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwa...
no cover page / publication year available
The process to develop this "National Traditional Medicine Policy" included a detailed situational analysis of traditional medicine in Liberia and a d...
The process to develop this "National Traditional Medicine Policy" included a detailed situational analysis of traditional medicine in Liberia and a d...
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to ... is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pandemic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
Technical Report
AIDS Medicines and diagnostics service
September 2016
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential ... as an integral component of treatment within the continuum of care, developing and disseminating the Model List of Essential Medicines (Model List). WHO is committed to supporting Member States in sharing best practices in selecting
essential medicines, and in developing processes for the selection of medicines for national essential medicines lists (national EMLs, or NEMLs) consistent with the evidence-based methods used for updating the WHO Model List.
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive ...
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national he...
This briefing note summarizes work undertaken by UN Women and WHO to inform the development of a module on violence against women 60 years and older that can be included in dedicated surveys on violence against women. It provides an overview of the challenges in the ..., measurement, and collection of data on violence against older women. It also makes recommendations to address some of the issues identified, with the aim of strengthening ongoing and future data collection efforts on violence against older women and increasing its availability.
Developed as part of the UN Women–WHO Global Joint Programme on Violence Against Women Data, this methodological briefing note is one in a series that aims to strengthen the measurement and data collection of violence against particular groups of women or specific aspects of violence against women. These briefing notes are meant for researchers, national statistics offices, and others involved in data collection on violence against women. They seek to contribute to strengthening the quality and availability of data on violence against women and enhance global, regional, and national level monitoring of progress towards its elimination.
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare...
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
Developed as part of the UN Women–WHO Global Joint Programme on Violence Against Women Data, this briefing note focuses on the measurement of violence against women with disability and is one in a series of methodological briefing notes for strengthening the measurement and data collection of viol...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of ... for acute and chronic conditions as well as opinions and perceptions about medicines. The survey was conducted in six regions. In each region, six reference public heath care facilities were selected among those participating in the Level II Facility Survey that was carried out in parallel. Within defined distances from each reference public health care facility, households were selected by purposive cluster sampling. A total of 1065 household respondents were interviewed by means of a structured paper questionnaire
